Intro Pullout Text Widget

Gut,

a leading international journal from BMJ and BSG, publishes cutting-edge gastroenterology and hepatology research and reviews

Impact Factor: 23.059
Citescore: 40.1
All metrics >>

Gut is a Plan S compliant Transformative Journal.

Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas of gastroenterology and hepatology. Regular features include articles by leading authorities describing novel mechanisms of disease and new management strategies, both diagnostic and therapeutic, likely to impact on clinical practice within the foreseeable future.

Gut is an official journal of the British Society of Gastroenterology and has two companion titles: Frontline Gastroenterology for education and practice and BMJ Open Gastroenterology for sound science clinical research.

Editor-in-Chief: Professor Emad El-Omar, University of New South Wales, Sydney, Australia
Meet the Editor and Editorial Board

TOP CITED ARTICLES
Read the most cited articles from Gut and BMJ Open Gastroenterology

SOCIAL MEDIA AND MULTIMEDIA
Keep up-to-date with Gut on Twitter and Facebook, and access videos on our YouTube channel.

The Gut blog is now live - read the latest posts from the team.

Podcast iconGut publishes podcasts discussing highlights from its issues. Subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.

 

Latest Content

COVID-19 Gastroenterology Collection

 

Our new online collection highlights all research relating to the COVID-19 pandemic published by Gut, Frontline Gastroenterology and BMJ Open Gastroenterology. It is updated regularly as new articles are published.

 

The COVID-19 collection includes original research, commentaries, letters and editorials from all three journals published with the British Society of Gastroenterology (BSG)

 

Visit the full BMJ Coronavirus resource collection for all the latest content from across our portfolio

 

Latest Visual Abstract

Visual Abstracts provide summaries of the latest research in a single, visual format

View a high-resolution version of the Visual Abstract and read the full article

Kwon et al VA

Altmetrics

Podcasts

Featured Video

Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity

To cite: Ng SC, Peng Y, Zhang L, et al. Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events. Gut. 2022;71:1106-1116.

Read the full article here: link
Objective: The gut microbiota plays a key role in modulating host immune response. We conducted a prospective, observational study to examine gut microbiota composition in association with immune responses and adverse events in adults who have received the inactivated vaccine (CoronaVac; Sinovac) or the mRNA vaccine (BNT162b2; BioNTech; Comirnaty).

Conclusions: Our study has identified specific gut microbiota markers in association with improved immune response and reduced adverse events following COVID-19 vaccines. Microbiota-targeted interventions have the potential to complement effectiveness of COVID-19 vaccines.

Related Content